Kyle Rickstad
Surgical · Hyannis, MANPI 1538564174
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 152 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AbbVie at 36.4% of the total. 2025 is the largest year on record at $1,267, more than ten times the $44 reported in 2022. Among surgical clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 152 payments — averaging $20.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Aimmune Therapeutics, Inc.$371
- Johnson & Johnson$260
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$196
- Takeda Pharmaceuticals U.S.A., Inc.$167
- Phathom Pharmaceuticals, Inc.$161
- plus $833 from 17 others
What the payments were for
- Food & beverage$3,129100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$3,129 in reported general payments places this provider in the 95th percentile of 312 surgical providers in Massachusetts.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ZenpepLipase/Protease/Amylase | 36 | $162,603 |
| CreonLipase/Protease/Amylase | 14 | $47,869 |
| Dexlansoprazole DrDexlansoprazole | 29 | $7,006 |
| TrulancePlecanatide | 12 | $6,738 |
| Pantoprazole Sodium | 189 | $3,110 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 12 | $1,952 |
| Famotidine | 127 | $1,712 |
| SuflavePeg 3350/Sod Sulf,chlr/Pot/Mag | 13 | $1,524 |
| Rabeprazole Sodium | 40 | $1,251 |
| Omeprazole | 99 | $944 |
| Lactulose | 12 | $778 |
| Esomeprazole Magnesium | 21 | $640 |
| Sucralfate | 11 | $562 |
| Dicyclomine Hcl | 23 | $348 |
| Ondansetron OdtOndansetron | 14 | $245 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Aimmune Therapeutics, Inc.Zenpep | $371 | $162,60336 claims |
| AbbVieCreon | $1,140 | $47,86914 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance | $196 | $6,73812 claims |
| Braintree Laboratories, Inc.Sutab, Suflave | $16 | $3,47625 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 312 surgical providers in Massachusetts.
Other surgical in Hyannis
- Julie WinnHyannis$2K
- Trenton HilesHyannis$2K
- Jennifer MillerHyannis$1K
- Donovan DriscollHyannis$1K
- Gregory DeconciliisWaltham$27K
- Lampros MinosWaltham$18K
- Nicolas DesjardinsSomerville$10K
- Robert KenneyChestnut Hill$8K
- Michael LlewellynBoston$8K
- Anargyros SkaliotisNorth Dartmouth$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.